Clinical Trials Browser

Phase 2 × Dermatitis, Atopic × abrocitinib × Clear all

NCT02780167 2019-05-02

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Phase 2 Completed

269 enrolled 31 charts

Dermatitis, Atopic, Lymphoma, Follicular